Rizatriptan use while Breastfeeding

Drugs containing Rizatriptan: Maxalt, Maxalt-MLT

Rizatriptan Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published experience exists with rizatriptan during breastfeeding. If rizatriptan is required by the mother, it is not a reason to discontinue breastfeeding; however, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Possible Effects on Lactation

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Sumatriptan, Eletriptan

References

Rizatriptan Identification

Substance Name

Rizatriptan

CAS Registry Number

144034-80-0

Drug Class

  • Serotonin Agonists

Administrative Information

LactMed Record Number

578

Information from the National Library of Medicine's LactMed Database.

Last Revision Date

2013-09-07

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

See Also...

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.

Hide
(web3)